Aarti Drugs Limited (BOM: 524348)

Aarti Drugs Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	24,228	25,286	27,161	24,886	21,548	18,061
Other Revenue	-	-	-	0	-	-
Revenue	24,228	25,286	27,161	24,886	21,548	18,061
Revenue Growth (YoY)	-12.06%	-6.90%	9.14%	15.49%	19.31%	15.71%
Cost of Revenue	15,912	16,970	19,102	17,022	13,319	11,876
Gross Profit	8,316	8,316	8,058	7,865	8,229	6,185
Selling, General & Admin	1,033	1,047	933.07	840.53	815.37	709.65
Other Operating Expenses	4,264	4,104	4,069	3,640	3,034	2,854
Operating Expenses	5,820	5,666	5,505	4,981	4,348	4,051
Operating Income	2,497	2,650	2,553	2,884	3,881	2,134
Interest Expense	-336.9	-335.15	-332.93	-207.48	-229.57	-337.26
Interest & Investment Income	-	24.97	7.02	23.16	36.2	11.28
Other Non Operating Income (Expenses)	0.04	15.33	14.92	0	-0	-
EBT Excluding Unusual Items	2,160	2,355	2,242	2,700	3,688	1,808
Asset Writedown	-	-	-	-	-30.42	-
Other Unusual Items	-	-	-	-	32.67	44.67
Pretax Income	2,160	2,355	2,242	2,700	3,690	1,853
Income Tax Expense	590.7	639.37	578.25	649.59	886.16	438.9
Earnings From Continuing Operations	1,569	1,716	1,664	2,050	2,804	1,414
Net Income to Company	1,569	1,716	1,664	2,050	2,804	1,414
Minority Interest in Earnings	-0.84	-1.73	-0.48	0.43	0.15	0.02
Net Income	1,568	1,714	1,663	2,050	2,804	1,414
Net Income to Common	1,568	1,714	1,663	2,050	2,804	1,414
Net Income Growth	-12.58%	3.07%	-18.89%	-26.88%	98.31%	57.55%
Shares Outstanding (Basic)	92	92	93	93	93	93
Shares Outstanding (Diluted)	92	92	93	93	93	93
Shares Change (YoY)	-0.89%	-0.72%	-	-0.64%	-	-1.20%
EPS (Basic)	17.09	18.65	17.96	22.14	30.09	15.17
EPS (Diluted)	17.01	18.65	17.96	22.14	30.09	15.17
EPS Growth	-12.21%	3.82%	-18.89%	-26.41%	98.31%	59.45%
Free Cash Flow	-	1,326	-314.97	-815.61	667.19	2,028
Free Cash Flow Per Share	-	14.42	-3.40	-8.81	7.16	21.75
Dividend Per Share	-	1.000	1.000	1.000	2.500	0.500
Dividend Growth	-	0%	0%	-60.00%	400.00%	100.00%
Gross Margin	34.32%	32.89%	29.67%	31.60%	38.19%	34.25%
Operating Margin	10.30%	10.48%	9.40%	11.59%	18.01%	11.82%
Profit Margin	6.47%	6.78%	6.12%	8.24%	13.01%	7.83%
Free Cash Flow Margin	-	5.24%	-1.16%	-3.28%	3.10%	11.23%
EBITDA	3,020	3,140	3,028	3,353	4,335	2,567
EBITDA Margin	12.47%	12.42%	11.15%	13.47%	20.12%	14.21%
D&A For EBITDA	523.94	489.77	475.43	469.4	453.3	432.82
EBIT	2,497	2,650	2,553	2,884	3,881	2,134
EBIT Margin	10.30%	10.48%	9.40%	11.59%	18.01%	11.82%
Effective Tax Rate	27.35%	27.15%	25.79%	24.06%	24.01%	23.69%
Revenue as Reported	24,274	25,326	27,182	25,000	21,593	18,076
Advertising Expenses	-	23.3	11.67	13.5	9.81	15.49

Source: S&P Capital IQ. Standard template. Financial Sources.